<DOC>
	<DOCNO>NCT00000420</DOCNO>
	<brief_summary>Safety Estrogens Lupus Erythematosus - National Assessment ( SELENA ) study test whether woman systemic lupus erythematosus ( SLE lupus ) safely use estrogen . We determine look effect oral contraceptive ( birth control pill , also know `` pill '' ) disease activity severity woman SLE . The result study show whether safe woman SLE use pill .</brief_summary>
	<brief_title>Safety Estrogens Lupus : Birth Control Pills</brief_title>
	<detailed_description>This study test effect exogenous female hormone disease activity severity woman systemic lupus erythematosus ( SLE ) . Physicians generally prescribe oral contraceptive ( OCs ) woman lupus widely hold view drug activate SLE . This practice base great incidence SLE woman men , biologic abnormality estrogen metabolism , murine model lupus , several anecdote patient disease flare receive exogenous hormone , single retrospective study patient preexist renal disease . By contrast , recent retrospective study suggest rate flare significantly increase patient take OCs . The preexist data insufficient warrant dismissal potentially important birth control option disease predominantly affect woman reproductive year whose fertility alter disease . Moreover , use OCs preserve fertility patient take cyclophosphamide use estrogens prevent coronary artery disease postmenopausal steroid-induced osteoporosis timely consideration . We attempt define , multicenter , randomize , double-blind , placebo-controlled trial , effect OCs contain low-dose synthetic estrogen progestins disease activity woman SLE . Because research hypothesis OCs increase risk flare , design study able detect minimal increase rate flare patient take OCs . We enroll patient inactive , stable , moderate disease require less 0.5 mg prednisone per kg bodyweight per day 2-year period randomize receive birth control pills placebo pill 12 month . During time , patient must use condom diaphragm birth control . We recruit patient clinic private practice include 4,000 woman SLE , belong minority group .</detailed_description>
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Norinyl</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>Female Unequivocal diagnosis SLE Inactive disease stable 0.5 mg/kg/day less predisone Must 18 39 year old nonsmoker Must 18 35 year old smoker Blood pressure &gt; 145/95 three occasion Deep vein , arterial thrombosis pulmonary embolus GPL &gt; 40 ; MPL &gt; 40 ; APL &gt; 50 ; dRVVT &gt; 37 sec APL antibody syndrome ever Gynecologic breast cancer Hepatic dysfunction liver tumor Diabetes mellitus ( NOT due steroid ) vascular disease Congenital hyperlipidemia Complicated migraine Severe disease activity ( SLEDAI &gt; 12 ) Increase SLEDAI &gt; 2 point 3 month Unexplained vaginal bleeding Use estrogen ( OCP ) &gt; 1 month time SLE diagnosis Present pregnancy Angina MI due APS Age &gt; 35 yr . smoker ; &gt; 39 yr . nonsmoker</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>SLE</keyword>
	<keyword>SELENA</keyword>
	<keyword>Oral contraceptive</keyword>
	<keyword>The pill</keyword>
	<keyword>Birth control</keyword>
	<keyword>Condom</keyword>
	<keyword>Diaphragm</keyword>
	<keyword>Estrogen</keyword>
	<keyword>Lupus</keyword>
	<keyword>Placebo</keyword>
</DOC>